Generation and characterization of a human single-chain fragment variable (scFv) antibody against cytosine deaminase from Yeast
<p>Abstract</p> <p>Background</p> <p>The ability of cytosine deaminase (CD) to convert the antifungal agent 5-fluorocytosine (5-FC) into one of the most potent and largely used anticancer compound such as 5-fluorouracil (5-FU) raised considerable interest in this enzyme...
Main Authors: | Tombesi Marina, Gellini Mara, Ascione Alessandro, Flego Michela, Santoro Filippo, Carpinelli Giulia, Zamboni Silvia, Mallano Alessandra, Podo Franca, Cianfriglia Maurizio |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2008-09-01
|
Series: | BMC Biotechnology |
Online Access: | http://www.biomedcentral.com/1472-6750/8/68 |
Similar Items
-
Development of a novel human phage display-derived anti-LAG3 scFv antibody targeting CD8+ T lymphocyte exhaustion
by: Alessandro Ascione, et al.
Published: (2019-10-01) -
Selection, affinity maturation, and characterization of a human scFv antibody against CEA protein
by: De Santis Rita, et al.
Published: (2006-02-01) -
Identification of Potent CD19 scFv for CAR T Cells through scFv Screening with NK/T-Cell Line
by: Chung Hyo Kang, et al.
Published: (2020-12-01) -
“Stapling” scFv for multispecific biotherapeutics of superior properties
by: Lauren E. Boucher, et al.
Published: (2023-12-01) -
INCREASING OF THE EXPRESSION OF RECOMBINANT scFv-ANTIBODIES EFFICIENCY
by: O.V. Galkin, et al.
Published: (2017-10-01)